Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 12

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 12
---
” refers to the Registration Rights Agreement, dated as of September 26, 2024, by and between CERo and certain
PIPE Investors.

“Third Securities Purchase Agreement” refers to the Securities Purchase Agreement, dated as of September 25, 2024, by and among CERo and certain
PIPE Investors, pursuant to which CERo agreed to issue and sell 2,853 shares of Series C Preferred Stock and warrants to purchase 81,752
shares of Common Stock (the “Series C Warrants”).

“Warrant Common Shares” refer to the shares of Common Stock underlying the Common Warrants.

“Warrant Preferred Shares” refer to the shares of Preferred Stock underlying the Preferred Warrants

“Warrants”
refer to the Rollover Warrants, the Private Placement Warrants, the Common Warrants, the Preferred Warrants and the Public Warrants.

<div align='center'>ix

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

This prospectus contains
forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act. All
statements other than statements of historical facts contained in this prospectus, including statements regarding our future results
of operations and financial position, business strategy, drug candidates, planned preclinical studies and clinical trials, results of
preclinical studies, clinical trials, research and development (“R&D”) costs, regulatory approvals, timing and likelihood
of success, as well as plans and objectives of management for future operations, are forward-looking statements. These statements involve
known and unknown risks, uncertainties and other important factors that are in some cases beyond our control and may cause our actual
results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied
by the forward-looking statements.

In some cases, you can identify
forward-looking statements by terms such as “may,” “will,” “should,” “would,” “expect,”
“plan,” “anticipate,” “could,” “intend,” “target,” “project,”
“believe,” “estimate,” “predict,” “potential,” or “continue” or the negative
of these terms or other similar expressions. Forward-looking statements contained in this prospectus include, but are not limited to,
statements about:

| ● | our financial performance; |

| ● | our ability to obtain additional                                                                                                    
 cash and the sufficiency of our existing cash, cash equivalents and market